Long term control of luteinized thecoma with sclerosing peritonitis with leuprorelin and tamoxifen treatment
Background: Luteinized thecoma with sclerosing peritonitis (LTSP) is a very rare condition, and its clinical management is not evidence-based. Here we describe a case of long-term disease control achieved with leuprorelin and tamoxifen therapy. Case presentation: A 18-year-old woman with acute abdom...
Main Authors: | L. Muratori, G. Gorzegno, P. Sperone, A. Andreozzi, M. Di Maio, G.V. Scagliotti |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-05-01
|
Series: | Gynecologic Oncology Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352578919300189 |
Similar Items
-
Sclerosing peritonitis associated with luteinized thecoma and elevated serum CA 125 levels: case report
by: Sabas Carlos Vieira, et al. -
Complete remission of peritonitis in a patient with luteinized thecomas of the type typically associated with sclerosing peritonitis using GnRH agonist and anti-estrogen
by: Maan Al Halabi, et al.
Published: (2015-11-01) -
Bilateral ovarian thecomas with sclerosing peritonitis mimicking advanced ovarian cancer
by: Yi-Chieh Chen, et al.
Published: (2022-05-01) -
Systemic recurrence of endometrial cancer more than 10 years after hysterectomy: a report of two cases and a brief review of the literature
by: Leonardo Muratori, et al.
Published: (2020-11-01) -
Tamoxifen therapy in encapsulating sclerosing peritonitis in patients after kidney transplantation.
by: Moustafellos, P, et al.
Published: (2006)